MOLBIO Share Price Target 2035

CAGR-based price projection for Molbio Diagnostics Limited (MOLBIO) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (18.1% CAGR)
Rs 6,763
2035 Target
Base Case (45.3% CAGR)
Rs 43,550
2035 Target
Bull Case (144.3% CAGR)
Rs 4,686,517
2035 Target

Current Market Snapshot

CMP: Rs 1,513.10
52W High: Rs 1,513.10
52W Low: Rs 1,036.65
1Y CAGR: 111.0%
3Y CAGR: 45.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,787 Rs 2,198 Rs 3,696
2028 Rs 2,110 Rs 3,192 Rs 9,029
2029 Rs 2,492 Rs 4,637 Rs 22,056
2030 Rs 2,944 Rs 6,735 Rs 53,878
2031 Rs 3,476 Rs 9,783 Rs 131,614
2032 Rs 4,106 Rs 14,211 Rs 321,506
2033 Rs 4,849 Rs 20,642 Rs 785,374
2034 Rs 5,727 Rs 29,982 Rs 1,918,506
2035 Rs 6,763 Rs 43,550 Rs 4,686,517

Other MOLBIO Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the MOLBIO share price target for 2035?

Based on historical growth analysis, the MOLBIO share price target for 2035 ranges from Rs 6,763 (conservative) to Rs 43,550 (base case) to Rs 4,686,517 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of MOLBIO?

The current market price of MOLBIO (Molbio Diagnostics Limited) is Rs 1,513.10. The 52-week high is Rs 1,513.10 and 52-week low is Rs 1,036.65.

Is MOLBIO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for MOLBIO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 18.1% CAGR), Base (45.3% CAGR), and Bull (optimistic at 144.3% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.